Just some questions: I’ve been doing some reading and took a...

Just some questions:

I’ve been doing some reading and took a small position in IMU today........ If anyone wants to add anything to my questions or insights please feel free to share:


1.Current MC fully diluted ?

2.Competitors comparison for oncolytic virus cure? IMU surely has competitors, does anyone have a comparison to go by?

3.Does IMU have their IP secured by patents?

4.“Imugene is acquiring the worldwide exclusive license to a promising oncolytic virus technology developed at the
City of Hope Cancer Centre in Los Angeles.”

Is this license related to the CF33? If so, How is it they and ASX company can acquire ?

5.Since, Human trials begin early next year starting with breast cancer, what kind of news flow is expected before then by the market?

6.Is it true ‘enough’, IMU clinical therapies are more advanced than Regeneron's cancer therapies before Regeneron was acquired for 1.6billion dollars………….. Or is this a misguided comparison?

Thanks in advance

All IMO & DYOR